Is the business good?
How good a business is MMED?
MiniMed Group, Inc. earns −7.6% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
−7.6%
Return on invested capital · cost of capital 9.0% · 17 points below what the capital costs: growth destroys value
- Operating margin
- −11%
Operating margin · Medical Instruments & Supplies median 5.8% · 12 months to Q4 2026
- R&D as % of revenue
- 14%
R&D as % of revenue
- Gross margin
- 54%
Gross margin
| Year | Operating margin |
|---|---|
| FY2024 | −2.8% |
| FY2025 | −5.4% |
| FY2026 | −6.1% |
Details›
- Gross margin12 months to Q4 2026
- 54%
- Operating margin12 months to Q4 2026
- −11%
- Net margin12 months to Q4 2026
- −16%
- R&D as % of revenue
- 14%
- Revenue, trailing twelve months
- $3.04B
- Net income, trailing twelve months
- −$486M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −7.6%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Medical Instruments & Supplies
The closest names by size in the same industry